CHAM
GSK icon

Clear Harbor Asset Management’s GSK GSK Stock Holding History

Clear Harbor Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-496
Closed -$23.3K – 480
2020
Q3 		$23.3K Buy
+496
New +$24.9K ﹤0.01% 483
2020
Q1 		– Sell
-496
Closed -$29.1K – 434
2019
Q4 		$29.1K Buy
+496
New +$27.6K 0.01% 466

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Clear Harbor Asset Management's GSK Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of GSK (GSK) in Q4 2020, closing a stake of 496 shares — an estimated $23.3K sold.

Clear Harbor Asset Management first reported a position in GSK in Q4 2019 and held it in 2 quarters. The position peaked at $29.1K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 496 GSK shares in Q4 2020, an estimated $23.3K.
  • Clear Harbor Asset Management first reported a position in GSK in Q4 2019 and held it in 2 quarters.
  • Clear Harbor Asset Management's GSK position peaked at $29.1K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.